Integrated Genomic Analysis of Chromosomal Alterations and Mutations in B-Cell Acute Lymphoblastic Leukemia Reveals Distinct Genetic Profiles at Relapse
Authors:
- Maribel Forero-CastroMFMaribel Forero-Castro
- Adrián MontañoAMAdrián Montaño
- Cristina RobledoCRCristina Robledo
- Alfonso García de CocaACAlfonso García de Coca
- José Luis FusterJFJosé Luis Fuster
- Natalia de Las HerasNHNatalia de Las Heras
- José Antonio QueizánJQJosé Antonio Queizán
- María Hernández-SánchezMHMaría Hernández-Sánchez
- Luis A. Corchete-SánchezLuis A. Corchete-Sánchez
- Marta Martín-IzquierdoMMMarta Martín-Izquierdo
- Jordi RiberaJRJordi Ribera
- José-María RiberaJRJosé-María Ribera
Open Access
- 4 July 2020
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 10 (7) , 455
Abstract
The clonal basis of relapse in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is complex and not fully understood. Next-generation sequencing (NGS), array comparative genomic hybridization (aCGH), and multiplex ligation-dependent probe amplification (MLPA) were carried out in matched diagnosis–relapse samples from 13 BCP-ALL patients to identify patterns of genetic evolution that could account for the phenotypic changes associated with disease relapse. The integrative genomic analysis of aCGH, MLPA and NGS revealed that 100% of the BCP-ALL patients showed at least one genetic alteration at diagnosis and relapse. In addition, there was a significant increase in the frequency of chromosomal lesions at the time of relapse (p = 0.019). MLPA and aCGH techniques showed that IKZF1 was the most frequently deleted gene. TP53 was the most frequently mutated gene at relapse. Two TP53 mutations were detected only at relapse, whereas the three others showed an increase in their mutational burden at relapse. Clonal evolution patterns were heterogeneous, involving the acquisition, loss and maintenance of lesions at relapse. Therefore, this study provides additional evidence that BCP-ALL is a genetically dynamic disease with distinct genetic profiles at diagnosis and relapse. Integrative NGS, aCGH and MLPA analysis enables better molecular characterization of the genetic profile in BCP-ALL patients during the evolution from diagnosis to relapse.Keywords
Funding Information
- Consejería de Educación, Junta de Castilla y León, Fondos FEDER (SA085U16, SA271P18)
- Proyectos de Investigación de la Gerencia Regional de Sanidad, SACYL (GRS 1847/A/18; GRS 2062/A/19)
- SYNtherapy (ERAPERMED2018-275)
- Instituto de Salud Carlos III (AC18/00093, CD19/00222, PI14/01971)
- FUCALHH (FUCALHH 2017)
- Centro de Investigación Biomédica en Red de Cáncer (CIBERONC CB16/12/00233)
- Fundación Científica Asociación Española Contra el Cáncer (Análisis genómico y funcional de la Leucemia Aguda Linfoblástica y en un modelo “in vitro” de modificación genética dirigida.)
- Universidad Pedagógica y Tecnológica de Colombia (Maribel Forero-Castro)
- Junta de Castilla y León (JCYL- EDU/556/2019)
This publication has 49 references indexed in Scilit:
- TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapyHaematologica, 2013
- Copynumber: Efficient algorithms for single- and multi-track copy number segmentationBMC Genomics, 2012
- Cytogenetic and Molecular Predictors of Outcome in Acute Lymphocytic Leukemia: Recent DevelopmentsCurrent Hematologic Malignancy Reports, 2012
- Genomic profiling of B-progenitor acute lymphoblastic leukemiaBest Practice & Research Clinical Haematology, 2011
- Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An UpdateJournal of Clinical Oncology, 2011
- Deletion ofIKZF1and Prognosis in Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2009
- Global Genomic Characterization of Acute Lymphoblastic LeukemiaSeminars in Hematology, 2009
- Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic LeukemiaScience, 2008
- Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemiaBlood, 2008
- Assessing the significance of chromosomal aberrations in cancer: Methodology and application to gliomaProceedings of the National Academy of Sciences, 2007